Medarex was an American biopharmaceutical company based in Princeton, New Jersey, with manufacturing facilities in Bloomsbury and Annandale, New Jersey...
6 KB (611 words) - 04:22, 3 October 2024
NASDAQ Global Select Market in the US. Genmab's technology is licensed from Medarex to create fully human high affinity antibodies using transgenic mice. These...
26 KB (1,906 words) - 04:10, 19 June 2024
ulcerative colitis. This drug was developed by Bristol-Myers Squibb and Medarex. Sandborn WJ, Colombel JF, Ghosh S, Sands BE, Dryden G, Hébuterne X, et al...
3 KB (138 words) - 07:01, 2 December 2023
California, Berkeley. Clinical development of anti-CTLA4 was initiated by Medarex, which was later acquired by Bristol-Myers Squibb. For his work in developing...
48 KB (4,684 words) - 06:38, 18 September 2024
entered in 2005 between Ono and Medarex.[citation needed] Through the research collaboration with Ono, it was invented at Medarex using its transgenic mice...
48 KB (4,959 words) - 05:40, 8 October 2024
was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School...
10 KB (842 words) - 19:21, 25 July 2024
during a major restructuring activity, BMS acquired the biotechnology firm Medarex as part of the company's "String of Pearls" strategy of alliances, partnerships...
96 KB (7,620 words) - 18:19, 2 October 2024
monoclonal antibody for treatment for arthritis, which was co-developed with Medarex, Inc. In 2004, the United States Department of Justice began investigating...
33 KB (3,169 words) - 05:41, 1 October 2024
was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School...
3 KB (179 words) - 20:34, 1 December 2023
(1985–2011) Massone (company) (????- ) Mayne (2005–2007) Maxygen (1997–2013) Medarex (1987–2009) Meda (1995–2016) MedImmune (1988–2019) Medivation (2004–2016)...
34 KB (2,175 words) - 05:58, 20 September 2024